Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 4,036,530	$ 548,331
Accounts receivable	271,424	231,269
Accounts receivable, related parties	0	5,100
Inventory	812,648	645,132
Prepaid expenses and other current assets	414,030	442,366
Prepaid expenses, related parties	464,549	35,609
Total Current Assets	5,999,181	1,907,807
Property and equipment	7,228,761	7,220,565
Right of use asset, related party	324,403	351,146
Other intangible assets, net of amortization	0	2,661
Other assets	287,080	0
TOTAL ASSETS	13,839,425	9,482,179
Current Liabilities
Accounts payable	234,287	335,605
Accounts payable, related parties	13,738	42,831
Accrued liabilities	22,861	0
Customer prepaid invoices and deposits	734,771	838,164
Notes payable, related parties	50,000	69,282
Convertible promissory notes payable	125,000	125,000
Other short term loans	138,252	0
Right of use liability, related party - current	111,300	109,552
Total Current Liabilities	1,430,209	1,520,434
Long Term Liabilities
Long-term debt	0	142,770
Right of use liability, related party	229,847	258,776
Total Liabilities	1,660,056	1,921,980
Stockholders' Equity
Preferred stock, $0.001 par value as of March 31, 2023 and December 31, 2022; 50,000,000 shares authorized as of March 31, 2023 and December 31, 2022, respectively	0	0
Common stock, $0.001 par value as of March 31, 2023 and December 31, 2022, respectively; 200,000,000 shares authorized as of March 31, 2023 and December 31, 2022, respectively. 28,281,505 and 23,436,505 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively.	28,281	23,436
Additional paid in capital	25,088,092	18,095,184
Accumulated deficit	(12,828,648)	(10,463,048)
Total Stockholders' Equity	12,287,725	7,655,572
Non-controlling interests	(108,356)	(95,373)
Total Equity Attributable to Hempacco Co., Inc.	12,179,369	7,560,199
LIABILITIES AND STOCKHOLDERS' EQUITY	13,839,425	9,482,179
Series A Preferred stock
Stockholders' Equity
Preferred stock, $0.001 par value as of March 31, 2023 and December 31, 2022; 50,000,000 shares authorized as of March 31, 2023 and December 31, 2022, respectively	$ 0	$ 0